A phase 1 trial of VIM0423 for People with Dystonia and Related Movement Disorders
Latest Information Update: 10 Jun 2025
At a glance
- Drugs VIM 0423 (Primary)
- Indications Dystonia; Movement disorders
- Focus Adverse reactions
Most Recent Events
- 10 Jun 2025 New trial record